Renergen Limited and ASP Isotopes Inc. have provided an update on the progress towards implementing their Scheme of Arrangement. The approval from the Competition Commission has been received, allowing the two companies to plan integration processes and begin collaborating. The written consent to the transfer of Renergen Shares in terms of the Offer has been obtained from the Industrial Development Corporation of South Africa and the United States International Development Finance Corporation, fulfilling the relevant Offer Condition. The deadline for the fulfilment of the remaining Conditions has been extended to 30 January 2026.
Furthermore, the date for Renergen’s repayment of the funding advanced to it has been extended to 30 January 2026. Both Renergen and ASP Isotopes Inc. remain committed to working together to obtain the required approvals as quickly as possible.
These updates were provided in a joint announcement dated 27 November 2025, and further salient dates and times for the Scheme will be announced once the remaining Conditions have been fulfilled. As a result of these announcements, the company's shares have moved -1.17% on the market, and are now trading at a price of $5.92. Check out the company's full 8-K submission here.
